Traditional Chinese medication for cardiovascular disease.
作者信息
Hao Pan-Pan, Jiang Fan, Chen Yu-Guo, Yang Jianmin, Zhang Kai, Zhang Ming-Xiang, Zhang Cheng, Zhao Yu-Xia, Zhang Yun
出版信息
Nat Rev Cardiol. 2015 Jun;12(6):318. doi: 10.1038/nrcardio.2015.60. Epub 2015 Apr 2.
PMID:25837526
Abstract
摘要
相似文献
1
Traditional Chinese medication for cardiovascular disease.用于治疗心血管疾病的中药
Nat Rev Cardiol. 2015 Jun;12(6):318. doi: 10.1038/nrcardio.2015.60. Epub 2015 Apr 2.
2
Traditional Chinese medication for cardiovascular disease.心血管疾病的中药治疗。
Nat Rev Cardiol. 2015 Feb;12(2):115-22. doi: 10.1038/nrcardio.2014.177. Epub 2014 Nov 11.
3
[Study on influencing factors of valid patents of compound traditional Chinese medicines for cardiovascular and cerebrovascular diseases on base of regression analysis].基于回归分析的心血管疾病复方中药有效专利影响因素研究
Zhongguo Zhong Yao Za Zhi. 2013 Mar;38(6):919-23.
4
[Enlightenment of adverse reaction monitoring on safety evaluation of traditional Chinese medicines].[中药不良反应监测对中药安全性评价的启示]
Zhongguo Zhong Yao Za Zhi. 2015 Apr;40(8):1620-3.
5
[Establishment of modern multi-component sustained-release preparations of oral traditional Chinese medicines].[现代中药口服多组分缓释制剂的建立]
Zhongguo Zhong Yao Za Zhi. 2013 Oct;38(19):3400-4.
6
7
An automated technique to identify potential inappropriate traditional Chinese medicine (TCM) prescriptions.一种识别潜在不适当中药处方的自动化技术。
Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):422-30. doi: 10.1002/pds.3976. Epub 2016 Feb 23.
8
[Regularity of drug use of patents in force of traditional Chinese medicine compounds in preventing and treating cardiovascular diseases on basis of frequency analysis].基于频次分析的中成药防治心血管疾病在研专利用药规律研究
Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(17):2661-6.
9
[Promoting development of new traditional Chinese medicine by combination disease-syndrome and multi-objective optimization research in prevention and treatment of cardiovascular disease].
Zhongguo Zhong Yao Za Zhi. 2015 Sep;40(17):3402-5.
10
[Study of cardiovascular and cerebrovascular disease in Chinese traditional medicines on Pb, Cr, Cd by AAS].[采用原子吸收光谱法对中药中铅、铬、镉含量进行的心血管和脑血管疾病研究]
Guang Pu Xue Yu Guang Pu Fen Xi. 2001 Dec;21(6):865-7.
引用本文的文献
1
Protective Effects of Polysaccharides Against Type 2 Diabetic Mice Induced by High-Fat Diet and Low-Dose Streptozotocin.多糖对高脂饮食和低剂量链脲佐菌素诱导的2型糖尿病小鼠的保护作用
Toxics. 2025 Mar 28;13(4):255. doi: 10.3390/toxics13040255.
2
Exploring the effects and mechanisms of Guizhigancao Decoction on heart failure using an integrated approach based on experimental support and network pharmacology strategy.基于实验支持和网络药理学策略的综合方法探索桂枝甘草汤对心力衰竭的作用及机制
J Tradit Complement Med. 2023 Apr 1;13(5):454-464. doi: 10.1016/j.jtcme.2023.03.010. eCollection 2023 Sep.
3
Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation and .齐留连通过抑制 NLRP3-ASC 炎性小体的激活来改善血管内皮功能障碍。
Pharm Biol. 2023 Dec;61(1):815-824. doi: 10.1080/13880209.2023.2208617.
4
Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study.中医药用于新型冠状病毒肺炎的治疗、预防及新型冠状病毒肺炎患者康复：一项证据图谱研究
Front Pharmacol. 2023 Jan 19;14:1069879. doi: 10.3389/fphar.2023.1069879. eCollection 2023.
5
Bidirectional regulatory effects of Cordyceps on arrhythmia: Clinical evaluations and network pharmacology.冬虫夏草对心律失常的双向调节作用：临床评价与网络药理学
Front Pharmacol. 2022 Aug 19;13:948173. doi: 10.3389/fphar.2022.948173. eCollection 2022.
6
Mechanism of and Ameliorates Hypertensive Renal Damage.机制并改善高血压性肾损伤。
Biomed Res Int. 2021 Apr 21;2021:5598351. doi: 10.1155/2021/5598351. eCollection 2021.
7
The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.中医药治疗 COVID-19 的直接证据和机制。
Biomed Pharmacother. 2021 May;137:111267. doi: 10.1016/j.biopha.2021.111267. Epub 2021 Jan 14.
8
Correlation between Mitochondrial Dysfunction, Cardiovascular Diseases, and Traditional Chinese Medicine.线粒体功能障碍、心血管疾病与中医之间的关联
Evid Based Complement Alternat Med. 2020 Oct 7;2020:2902136. doi: 10.1155/2020/2902136. eCollection 2020.
9
Exploring Molecular Mechanism of Huangqi in Treating Heart Failure Using Network Pharmacology.基于网络药理学探索黄芪治疗心力衰竭的分子机制
Evid Based Complement Alternat Med. 2020 Apr 23;2020:6473745. doi: 10.1155/2020/6473745. eCollection 2020.
10
Untargeted Safety Pharmacology Screen of Blood-Activating and Stasis-Removing Patent Chinese Herbal Medicines Identified Nonherbal Ingredients as a Cause of Organ Damage in Experimental Models.活血化瘀类中药专利制剂的非靶向安全药理学筛选表明，在实验模型中，非草药成分是器官损伤的一个原因。
Front Pharmacol. 2019 Sep 12;10:993. doi: 10.3389/fphar.2019.00993. eCollection 2019.
本文引用的文献
1
Traditional Chinese medication for cardiovascular disease.心血管疾病的中药治疗。
Nat Rev Cardiol. 2015 Feb;12(2):115-22. doi: 10.1038/nrcardio.2014.177. Epub 2014 Nov 11.
Zotero 插件